by Qin Huang Blood Volume 122(1):6-6 July 4, 2013

Slides:



Advertisements
Similar presentations
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Advertisements

Staff Oncologist, Mayo Clinic Arizona
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.
Multiple Myeloma Alan Johns, M.D. Kristine Krafts, M.D.
NYU Medical Grand Rounds Clinical Vignette Ankit Parikh MD, PGY-2 January 6, 2009 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Multiple Myeloma Definition:
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
Multiple Myeloma Definition:
CASE 5 56 yr-old man HIV Asymptomatic CD4 840 HIV viral load
Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney Sophina Hissaund FY2.
Treatment Multiple Myeloma. Symptomatic/progressive myeloma: Systemic therapy - to control progression of myeloma Supportive care - to prevent serious.
Multiple Myeloma Morning Report July 21, 2009 Lindsay Kruska.
MLAB 1415: H EMATOLOGY K ERI B ROPHY -M ARTINEZ Chapter 26: Lymphoid Malignancies Part Two.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Jesse C James MD AM Report May 7,  Proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein  Malignant.
Why Are Biometric Screenings Important? Lisa Fernandez.
How I treat enteropathy-associated T-cell lymphoma by Antonio Di Sabatino, Federico Biagi, Paolo G. Gobbi, and Gino R. Corazza Blood Volume 119(11):
Multiple Myeloma March 13, 2012 Suzanne R. Fanning, DO Greenville Health System.
Multiple Myeloma: Is it now a curable disease?
CONCEPT MAP CONCEPT MAP. 42 y/o male, CC: EDEMA ON BILATERAL EXTREMITIES. Diagnosed with a benign cystic lesion 8 yrs ago S/Sx: BONE PAINS, EASY FATIGUABILITY.
Case Study Multiple Myeloma.
Clinical Procedures and Test
Rare Pedal Manifestation of Diffuse Multiple Myeloma Lesions
MLAB Hematology Keri Brophy-Martinez
Volume 140, Issue 6, Pages (December 2011)
Dr WAQAR ASST. PROFESSOR INTERNAL MEDICINE
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Triple-Negative Breast Cancer
Bone Marrow Graft-versus-Host Disease: Evaluation of Its Clinical Impact on Disrupted Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplantation 
by Rahul Matnani, and Karthik A. Ganapathi
Patient A.
by Christopher Dittus, and Dana Semmel
by Ambra Paolini, and Goretta Bonacorsi
Leukemia Case 1.
by Michele Paessler, and John Choi
Anaplastic variant of plasma cell myeloma with Dutcher bodies
by Vishal Bhatnagar, and Ashkan Emadi
CNS involvement in DLBCL
Countless mycobacteria inside a macrophage
A young patient with multiple myeloma
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection by Koen Van Besien, Sonali Smith,
Intravascular large B-cell lymphoma with leukemic component
Parasternal mass Blood Volume 113(6): February 5, 2009
Primary Central Nervous System Lymphoma
Metastatic epithelioid angiosarcoma with bone marrow involvement
Rare and strange invader
Hyperviscosity syndrome
Male Genital Tract I, Case 1
by Toru Takahashi, and Masafumi Matsuguma
Erythroid leukemia evolving from multiple myeloma
The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients with Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell.
Light chain proximal tubulopathy
Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell.
Recurrent Brachial Neuritis Attacks in Presentation of B-Cell Lymphoma
Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase  Shan-Chi.
Lymphocyte Subset Recovery and Outcome after Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma  Jessica Rueff, Michael Medinger,
Quizpage answers june 2003 American Journal of Kidney Diseases
An Unusual Cause of Pulmonary Nodules After Stem Cell Transplantation
by Geling Li, Emily Waite, and Julie Wolfson
John R. Goldblum, MD, Thomas W. Rice, MD, Gregory Zuccaro, MD, Joel E
Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant  Ahmad Hatem Mattour,
Quiz page answers January 2005
Cortical Petechial Hemorrhage, Leukoencephalopathy, and Subacute Dementia Associated With Seizures Due to Cerebral Amyloid Angiopathy  Peter L. Silbert,
Fig. 4. Pathologic findings of Case 2
A previously healthy 43-year-old man with chronic alcoholism presented to a rural medical center with a 2-week history of confusion, fever, dyspnea, dizziness,
Metastatic malignant melanoma in the bone marrow
How I treat primary CNS lymphoma
Presentation transcript:

Isolated plasmacytoma involving the brain parenchyma and cerebral spinal fluid by Qin Huang Blood Volume 122(1):6-6 July 4, 2013 ©2013 by American Society of Hematology

A 32-year-old man with an Ig A-λ plasma cell myeloma was diagnosed in early 2011. A 32-year-old man with an Ig A-λ plasma cell myeloma was diagnosed in early 2011. He underwent chemotherapy with bortezomib, doxorubicin, and dexamethasone and achieved a complete response. In August 2011, the patient underwent an autologous stem cell transplant with high-dose melphalan. The patient recovered uneventfully. He presented in December 2011 with a severe headache requiring hospitalization. The patient had mild anemia (hemoglobin, 10.6 g/dL) but normal white blood cell and platelet counts. His calcium and creatinine levels were in the normal range. Bone marrow biopsy and serum protein electrophoresis/immunofixation were unremarkable. Computed tomography/magnetic resonance imaging scans of the brain showed multiple foci of hemorrhage with surrounding edema (panel A). A possible infectious etiology or embolic event was suspected clinically. An open excisional biopsy of the right frontal lesion of the brain was performed. The hematoxylin and eosin histologic sections showed brain parenchyma infiltrated by sheets of neoplastic cells with a plasmacytoid cellular morphology with round nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm (panel B). Bi- or multinucleated tumor cells were frequent. The tumor cells were positive for CD138 and CD56 with λ light chain restriction, consistent with plasmacytoma. The cerebrospinal fluid (CSF) contained numerous neoplastic plasma cells (panel C). Isolated plasmacytoma of the brain with CSF involvement after a complete response from an autologous stem cell transplant is a rare event. Qin Huang Blood 2013;122:6 ©2013 by American Society of Hematology